Efficacy of Anti Ectera drop in Prevention of neonatal Jaundice

Phase 3

• Conditions: eonatal jaundice.; Neonatal Hyperbilirubinaemia; KA87

• Registration Number: IRCT20201129049527N2
• Lead Sponsor: Kerman University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

Parent’s consent to participate in the study
Mothers be more than 18 years old and under 35 years old
The mothers of the neonates without any an underlying disease
The neonate's mother does not have high blood pressure or gestational diabetes
Term newborn
Apgar score>7
Neonate weighs less than 2.5 or more than 4 kg
Neonate without congenital abnormalities

Exclusion Criteria

Diagnosis of G6PD in neonate
Incidence of jaundice on the first day of birth
Diagnosis of infection in neonate

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence and extent of jaundice in neonates. Timepoint: Before and after prescription of Anti-Ectera drops. Method of measurement: Laboratory test for bilirubin.